Robert Charles Peterson has sold BTMD and made no open-market buys since Jul 2024

Robert Charles Peterson is a corporate insider and senior finance executive who serves as Chief Financial Officer of Biote Corp. (NASDAQ: BTMD), a hormone optimization and healthy aging company based in Irving, Texas.( He was appointed CFO of Biote Corp. in January 2024, becoming the company’s principal accounting and financial officer.( In 2026, Peterson was additionally named Interim Chief Executive Officer and Director, expanding his responsibilities to include overall leadership of the company while continuing as CFO.( As a key insider, he has been granted and actively manages equity awards and option grants, and has periodically sold portions of his Biote holdings, reflecting his ongoing participation in the company’s long‑term incentive and ownership programs.(

Prior to his current role at Biote, Peterson built a career in corporate finance and executive management, including serving as Chief Financial Officer and Executive Vice President at Virbac Corporation, a global animal health company.( Public compensation disclosures indicate he receives a mix of salary, bonus, stock options, and other incentives in his Biote role, underscoring his position as a central figure in the company’s financial and strategic decision‑making.( Available public records and professional profiles do not provide detailed information about his academic background, but consistently describe him as an experienced CFO and strategic business leader with a focus on operational and financial excellence.(

Written by Perplexity from public sources.